Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype-Reference-Cited by-同舟云学术

Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype

Published:2024-04-07 Issue:1 Volume:147 Page:
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Nassiri Farshad,Ajisebutu Andrew,Patil Vikas,Mamatjan Yasin,Liu Jeff,Wang Justin Z.,Voisin Mathew R.,Nejad Romina,Mansouri Sheila,Karimi Shirin,Chakravarthy Ankur,Chen Eric,De Carvalho Daniel D.,Aldape Kenneth,Zadeh Gelareh

Funder

Canadian Cancer Society

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00401-024-02713-1.pdf

Reference38 articles.

1. Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD et al (2014) Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30:1363–1369. https://doi.org/10.1093/bioinformatics/btu049

2. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108–112. https://doi.org/10.1038/nature08460

3. Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E et al (2019) Longitudinal molecular trajectories of diffuse glioma in adults. Nature 576:112–120. https://doi.org/10.1038/s41586-019-1775-1

4. Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C et al (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol 139:603–608. https://doi.org/10.1007/s00401-020-02127-9

5. Brat DJ, Verhaak RGW, Aldape KD, Yung WKA, Salama SR, Cooper LAD et al (2015) Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/NEJMoa1402121